Public health significance of supplementation or fortification of grain products with folic acid

Food and Nutrition Bulletin

Volumn 29, Issue 2 SUPPL., 2008, Pages

  Selhub, Jacob ^a   Rosenberg, Irwin H ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Folic acid; Fortification; Grain; Neural tube defects

Indexed keywords

CEREAL; CONFERENCE PROCEEDING; FOOD SUPPLEMENTATION; PUBLIC HEALTH;

EID: 48249093061     PISSN: 03795721     EISSN: None     Source Type: Journal    
DOI: 10.1177/15648265080292s120     Document Type: Conference Paper

References (32)

1. Wills L. Treatment of "pernicious anemia of pregnancy and tropical anemia, with special reference to yeast extract. Br Med J 1931;1:1059-64.
2. Wills L, Evans BDF. Tropical macrocytic anemia: Its relation to pernicious anemia. Lancet 1938;2:416-21.
3. Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians 1962;75:307-20.
4. Hibbard BM, Hibbard ED. Folate deficiency in pregnancy. Br Med J 1968;4:452-3.
5. Hibbard BM, Hibbard ED. Folate metabolism and reproduction. J Physiol 1971;219:16P.
6. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child 1976; 51:944-50.
7. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-40.
8. Scott JM, Weir DG, Kirke PN. Folate and neural tube defects. In: Bailey L, ed. Folate in health and disease. New York: Marcel Dekker, 1995:329-60.
9. 12 and birth defects. Forum Nutr 2003;56:45-9.
10. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485-90.
11. Medical Research Council Vitamin Study. Lancet 1984; 1:1308.
12. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
13. Butterworth CE, Hatch KD, Gore H, Mueller H, Krumdieck CL. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 1982;35:73-82.
14. Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Jacques PF, Dworkin L, Selhub J. Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients. Transplantation 2000;69:2128-31.
15. Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988;43:414-21.
16. Frosst P, Zhang Z, Pai A, Rozen R. The methylenetetrahydrofolate reductase (Mthfr) gene maps to distal mouse chromosome 4. Mamm Genome 1996;7:864-5.
17. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
18. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002;99:5606-11.
19. Bagley PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 1998;95:13217-20.
20. Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol 2004;46:843-51.
21. Ramaekers VT, Rothenberg SP, Sequeira JM, Opladen T, Blau N, Quadros EV, Selhub J. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 2005;352:1985-91.
22. Rothenberg SP, da Costa MP, Sequeira JM, Cracco J, Roberts JL, Weedon J, Quadros EV. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med 2004;350:34-42.
23. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
24. Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002;132:2792-8.
25. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
26. Yang Q, Botto LD, Erickson JD, Berry RJ, Sambell C, Johansen H, Friedman JM. Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 2006;113:1335-43.
27. 12 intake and cognitive decline among community-dwelling older persons. Arch Neurol 2005;62:641-5.
28. Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 1997;65:1790-5.
29. Goldman ID, Zhao R. Molecular, biochemical, and cellular pharmacology of pemetrexed. Semin Oncol 2002;29(6 suppl 18):3-17.
30. Spector R, Lorenzo AV. Folate transport by the choroid plexus in vitro. Science 1975;187:540-2.
31. Spector R, Lorenzo AV. Folate transport in the central nervous system. Am J Physiol 1975;229:777-82.
32. Bagley PJ, Selhub J. Analysis of folate form distribution by affinity followed by reversed- phase chromatography with electrical detection. Clin Chem 2000;46:404-11.